EQS-News
Formycon invites to the Annual General Meeting on June 12, 2024 in Munich
- Formycon AG invites to Annual General Meeting on June 12, 2024 in Munich
- Proposal to expand Supervisory Board to five members with international focus
- Three new candidates with industry and financial expertise stand for election
EQS-News: Formycon AG / Key word(s): AGM/EGM/Personnel Press release // 07 May 2024 |
Formycon invites to the Annual General Meeting on June 12, 2024 in Munich
- Formycon proposes to the Annual General Meeting a more international focus and expansion of the Supervisory Board to five members
- With Colin Bond, Dr. Bodo Coldewey and Nicholas Haggar, three new candidates with relevant industry and financial expertise stand for election
- Dr. Olaf Stiller and Peter Wendeln to step down from the Supervisory Board by mutual agreement
Planegg-Martinsried, Germany – Formycon AG (FSE: FYB, "Formycon") has published the invitation to its Annual General Meeting on Wednesday, June 12, 2024. The Annual General Meeting will be held as an in-person event for shareholders and their proxies from 11 a.m. (CEST) at the Haus der Bayerischen Wirtschaft in Munich.
The agenda for this year's Annual General Meeting includes proposed resolutions for the election of two new members to the Supervisory Board, an increase in the size of the Supervisory Board from four to a total of five members and the election of a new member to the expanded Supervisory Board. The aim is to achieve a more international focus and expand the industrial and financial expertise of the Supervisory Board with new independent members.
In agreement with Formycon, the Chairman of the Supervisory Board, Dr. Olaf Stiller, and his Deputy, Peter Wendeln, have decided to resign from the Supervisory Board after more than 10 years of service with effect from the end of the Annual General Meeting on June 12, 2024.
The Executive Board of Formycon AG therefore proposes to the Annual General Meeting that a total of three new members be elected to the Supervisory Board. Dr. Bodo Coldewey, Managing Director of WEGA Invest GmbH, the family office of the Wendeln family, and Nicholas Haggar, currently CEO of healthqube Ltd and long-standing executive at major pharmaceutical companies, are standing for election to replace the outgoing members. Colin Bond, currently CFO of Sandoz Group AG, will be proposed as a new member of the expanded Supervisory Board effective 1 October 2024.